Chemomab Therapeutics Ltd.

Chemomab Therapeutics Ltd.verified

CMMB

Price:

$2.52

Market Cap:

$15.51M

Chemomab Therapeutics Ltd., a clinical-stage biotech company, discovers and develops therapeutics for the treatment of inflammation and fibrosis. The company's lead clinical product candidate is CM-101, a humanized monoclonal antibody that hinders the basic function of soluble chemokine CCL24 for the treatment of primary sclerosing cholangitis (PSC) and systemic sclerosis (SSc). The company was formerly known as Anchiano Therapeutics Ltd. and changed its name to Chemomab Therapeutics Ltd. in March 2021. Chemomab Therapeutics Ltd. was incorporated in 2011 and is based in Tel Aviv, Israel.

Industry

Biotechnology

IPO Date

2019-02-12

Stock Exchange

NASDAQ

Ticker

CMMB

The Current Ratio as of December 2025 (TTM) for Chemomab Therapeutics Ltd. (CMMB) is 10.49

According to Chemomab Therapeutics Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 10.49. This represents a change of 48.64% compared to the average of 7.06 of the last 4 quarters.

Chemomab Therapeutics Ltd. (CMMB) Historical Current Ratio (quarterly & annually)

How has CMMB Current Ratio performed in the past?

The mean historical Current Ratio of Chemomab Therapeutics Ltd. over the last ten years is 6.15. The current 10.49 Current Ratio has changed 16.95% with respect to the historical average. Over the past ten years (40 quarters), CMMB's Current Ratio was at its highest in in the September 2021 quarter at 40.39. The Current Ratio was at its lowest in in the June 2016 quarter at 0.

Quarterly (TTM)
Annual

Average

6.15

Median

4.37

Minimum

0.59

Maximum

23.66

Chemomab Therapeutics Ltd. (CMMB) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Chemomab Therapeutics Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = Infinity%

Maximum Annual Current Ratio = 23.66

Minimum Annual Increase = -73.86%

Minimum Annual Current Ratio = 0.59

Quarterly (TTM)
Annual
YearCurrent RatioChange
20244.9815.40%
20234.32-30.15%
20226.18-73.86%
202123.66162.95%
20209.00103.58%
20194.4211.12%
20183.98574.71%
20170.59-71.47%
20162.07-11.10%
20152.32Infinity%

Chemomab Therapeutics Ltd. (CMMB) Average Current Ratio

How has CMMB Current Ratio performed in the past?

The current Current Ratio of Chemomab Therapeutics Ltd. (CMMB) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

5.16

5-year avg

9.63

10-year avg

6.15

Chemomab Therapeutics Ltd. (CMMB) Current Ratio vs. Peers

How is CMMB’s Current Ratio compared to its peers?

Chemomab Therapeutics Ltd.’s Current Ratio is greater than Kazia Therapeutics Limited (0.21), greater than Ocean Biomedical, Inc. (0.06), greater than Theriva Biologics, Inc. (1.19), greater than PMGC Holdings Inc. (1.79), greater than Can-Fite BioPharma Ltd. (3.60), less than BioVie Inc. (15.83), greater than XORTX Therapeutics Inc. (1.78), greater than InMed Pharmaceuticals Inc. (6.99), greater than CERo Therapeutics Holdings, Inc. (0.30), greater than Galmed Pharmaceuticals Ltd. (8.71),

Build a custom stock screener for Chemomab Therapeutics Ltd. (CMMB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Chemomab Therapeutics Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Chemomab Therapeutics Ltd. (CMMB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Chemomab Therapeutics Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Chemomab Therapeutics Ltd.'s Current Ratio?

How is the Current Ratio calculated for Chemomab Therapeutics Ltd. (CMMB)?

What is the highest Current Ratio for Chemomab Therapeutics Ltd. (CMMB)?

What is the 3-year average Current Ratio for Chemomab Therapeutics Ltd. (CMMB)?

What is the 5-year average Current Ratio for Chemomab Therapeutics Ltd. (CMMB)?

How does the current Current Ratio for Chemomab Therapeutics Ltd. (CMMB) compare to its historical average?